Study to Assess Adverse Events and Change in Disease Activity of Oral Cariprazine Capsules in Adult Participants With Schizophrenia
Phase 3
Recruiting
- Conditions
- Schizophrenia
- Registration Number
- JPRN-jRCT2031220096
- Lead Sponsor
- Otani Tetsuya
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 402
Inclusion Criteria
Diagnosed with schizophrenia at least 1 year before informed consent.
- Experienced a persistent psychotic episode within 1 month prior to screening requiring treatment modifications as judged by the investigator or sub-investigator.
Exclusion Criteria
- History of clinically significant medical conditions or any other reason that the investigator (or subinvestigator) determines would interfere with the participant's participation in this study or would make the participant an unsuitable candidate to receive study drug.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method